Samsung Bioepis Releases its First US Biosimilar Market Report, Providing Insights on Pricing Trends and Usage Across Molecules
To be published on quarterly basis, with updated average sales price (ASP) and National Average Drug Acquisition Cost (NADAC) trends Biosimilars continue to play a crucial role in driving down healthcare costs INCHEON, Korea, April 17, 2023 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. today released the first edition of its Biosimilar Market Report which […]